Radiotherapy and Renal Cell Carcinoma: A Continuing Saga

被引:12
作者
Spyropoulou, Despoina [1 ]
Tsiganos, Panagiotis [2 ]
Dimitrakopoulos, Foteinos-Ioannis [3 ,4 ]
Tolia, Maria [5 ]
Koutras, Angelos [3 ]
Velissaris, Dimitris [6 ,7 ]
Lagadinou, Maria [6 ]
Papathanasiou, Nikolaos [8 ]
Gkantaifi, Areti [9 ]
Kalofonos, Haralabos [3 ]
Kardamakis, Dimitrios [1 ]
机构
[1] Univ Patras, Med Sch, Dept Radiat Oncol, Univ Campus, Patras 26504, Greece
[2] Univ Patras, Dept Med, Clin Radiol Lab, Patras, Greece
[3] Univ Hosp Patras, Dept Med, Div Oncol, Patras, Greece
[4] Univ Patras, Med Sch, Clin & Mol Oncol Lab, Patras, Greece
[5] Univ Crete, Med Sch, Univ Hosp Heraklion, Radiotherapy Dept, Iraklion, Greece
[6] Univ Hosp Patras, Emergency Dept, Patras, Greece
[7] Univ Hosp Patras, Internal Med Dept, Patras, Greece
[8] Univ Hosp Patras, Nucl Med & PET CT Dept, Patras, Greece
[9] Interbalkan Med Ctr, Radiotherapy Dept, Thessaloniki, Greece
来源
IN VIVO | 2021年 / 35卷 / 03期
关键词
Renal cell cancer; radiotherapy; radioresistance; radiosensitivity; oligometastatic disease; stereotactic body radiation therapy; review; EXTERNAL-BEAM RADIOTHERAPY; STEREOTACTIC BODY RADIOTHERAPY; LONG-TERM OUTCOMES; BRAIN METASTASES; POSTOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; PROGNOSTIC-FACTORS; SYSTEMIC THERAPY; STAGE-II;
D O I
10.21873/invivo.12389
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Renal cell carcinoma (RCC) is one of the most aggressive malignancies of the genito-urinary tract, having a poor prognosis especially in patients with metastasis. Surgical resection remains the gold standard for localized renal cancer disease, with radiotherapy (RT) receiving much skepticism during the last decades. However, many studies have evaluated the role of RT, and although renal cancer is traditionally considered radio-resistant, technological advances in the RT field with regards to modern linear accelerators, as well as advanced RT techniques have resulted in breakthrough therapeutic outcomes. Additionally, the combination of RT with immune checkpoint inhibitors and targeted agents may maximize the clinical benefit. This review article focuses on the role of RT in the therapeutic management of renal cell carcinoma.
引用
收藏
页码:1365 / 1377
页数:13
相关论文
共 89 条
[1]   Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy [J].
Alexander, Gregory S. ;
Palmer, Joshua D. ;
Tuluc, Madalina ;
Lin, Jianqing ;
Dicker, Adam P. ;
Bar-Ad, Voichita ;
Harshyne, Larry A. ;
Louie, Jennifer ;
Shaw, Colette M. ;
Hooper, D. Craig ;
Lu, Bo .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
[2]   Survival After Complete Surgical Resection of Multiple Metastases From Renal Cell Carcinoma [J].
Alt, Angela L. ;
Boorjian, Stephen A. ;
Lohse, Christine M. ;
Costello, Brian A. ;
Leibovich, Bradley C. ;
Blute, Michael L. .
CANCER, 2011, 117 (13) :2873-2882
[3]   Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant? [J].
Amini, Arya ;
Altoos, Basel ;
Bourlon, Maria T. ;
Bedrick, Edward ;
Bhatia, Shilpa ;
Kessler, Elizabeth R. ;
Flaig, Thomas W. ;
Fisher, Christine M. ;
Kavanagh, Brian D. ;
Lam, Elaine T. ;
Karam, Sana D. .
PRACTICAL RADIATION ONCOLOGY, 2015, 5 (06) :E589-E596
[4]  
Blanco Angel I, 2011, Cancers (Basel), V3, P4010, DOI 10.3390/cancers3044010
[5]  
Buti Sebastiano, 2020, Cancer Treat Res Commun, V22, P100161, DOI 10.1016/j.ctarc.2019.100161
[6]   Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences [J].
Buttigliero, Consuelo ;
Allis, Simona ;
Tucci, Marcello ;
Zichi, Clizia ;
Leone, Gianmarco ;
Di Stefano, Rosario Francesco ;
Redda, Maria Grazia Ruo ;
Ricardi, Umberto ;
Scagliotti, Giorgio Vittorio ;
Di Maio, Massimo ;
Filippi, Andrea Riccardo .
CANCER TREATMENT REVIEWS, 2018, 69 :215-223
[7]  
Calvo FA, 2013, STRAHLENTHER ONKOL, V189, P129, DOI 10.1007/s00066-012-0272-3
[8]   Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: A retrospective study [J].
Cannady, SB ;
Cavanaugh, KA ;
Lee, SY ;
Bukowski, RM ;
Olencki, TE ;
Stevens, GHJ ;
Barnett, GH ;
Suh, JH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (01) :253-258
[9]   Evaluation and Management of the Renal Mass [J].
Chen, David Y. T. ;
Uzzo, Robert G. .
MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (01) :179-+
[10]   Systemic Therapy for Metastatic Renal-Cell Carcinoma [J].
Choueiri, Toni K. ;
Motzer, Robert J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (04) :354-366